References
- WeberCNoelsHAtherosclerosis: current pathogenesis and therapeutic optionsNat Med201117111410142210.1038/nm.253822064431
- FeigJEParathathSRongJXReversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaquesCirculation2011123998999810.1161/CIRCULATIONAHA.110.98414621339485
- WilliamsKJFeigJEFisherEARapid regression of atherosclerosis: insights from the clinical and experimental literatureNat Clin Pract Cardiovasc Med2008529110210.1038/ncpcardio108618223541
- WeberCZerneckeALibbyPThe multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse modelsNat Rev Immunol200881080281510.1038/nri241518825131
- LibbyPInflammation in atherosclerosisNature2002420691786887410.1038/nature0132312490960
- MinKChoKKwonTKThe effect of oxidized low density lipoprotein (oxLDL)-induced heme oxygenase-1 on LPS-induced inflammation in RAW 264.7 macrophage cellsCell Signal20122461215122110.1016/j.cellsig.2012.02.00122349240
- TsimikasSMillerYIOxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular diseaseCurr Pharm Des2011171273721226665
- TabasIMacrophage death and defective inflammation resolution in atherosclerosisNat Rev Immunol2010101364610.1038/nri267519960040
- MooreKJSheedyFJFisherEAMacrophages in atherosclerosis: a dynamic balanceNat Rev Immunol2013131070972110.1038/nri352023995626
- TatsumiKMackmanNTissue factor and atherothrombosisJ Atheroscler Thromb201522654354910.5551/jat.3094026016513
- SteffelJTissue factor in cardiovascular diseases: molecular mechanisms and clinical implicationsCirculation2006113572273110.1161/CIRCULATIONAHA.105.56729716461845
- MackmanNRole of tissue factor in hemostasis, thrombosis, and vascular developmentArterioscler Thromb Vasc Biol20042461015102210.1161/01.ATV.0000130465.23430.7415117736
- SchecterADRollinsBJZhangYJTissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cellsJ Biol Chem19972724528568285739353321
- SchepersAEeftingDBontaPIAnti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivoArterioscler Thromb Vasc Biol20062692063206910.1161/01.ATV.0000235694.69719.e216825596
- NiuJKolattukudyPERole of MCP-1 in cardiovascular disease: molecular mechanisms and clinical implicationsClin Sci (Lond)200911739510910.1042/CS2008058119566488
- LibbyPInflammation in AtherosclerosisArterioscler Thromb Vasc Biol20123292045205110.1161/ATVBAHA.108.17970522895665
- LiSChenHRenJMicroRNA-223 inhibits tissue factor expression in vascular endothelial cellsAtherosclerosis2014237251452010.1016/j.atherosclerosis.2014.09.03325463083
- ten CateHTissue factor-driven thrombin generation and inflammation in atherosclerosisThromb Res2012129Suppl 2S38S4010.1016/j.thromres.2012.02.028
- ScharlachCKratzHWiekhorstFSynthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron stainingNanomedicine-Uk20151151085109510.1016/j.nano.2015.01.002
- YeKQinJPengZPolyethylene glycol-modified dendrimer-entrapped gold nanoparticles enhance CT imaging of blood pool in atherosclerotic miceNanoscale Res Lett20149152910.1186/1556-276X-9-52925288918
- NoukeuLCWolfJYuanBBanerjeeSNguyenKTNanoparticles for detection and treatment of peripheral arterial diseaseSmall2018e180064410.1002/smll.20180064429952061
- NieSZhangJMartinez-ZaguilanRDetection of atherosclerotic lesions and intimal macrophages using CD36-targeted nanovesiclesJ Control Release2015220Pt A617010.1016/j.jconrel.2015.10.00426450668
- MlinarLBChungEJWonderEATirrellMActive targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micellesBiomaterials201435308678868610.1016/j.biomaterials.2014.06.05425043572
- ChungEJMlinarLBNordKMonocyte-targeting supramolecular micellar assemblies: a molecular diagnostic tool for atherosclerosisAdv Healthc Mater20154336737610.1002/adhm.20140033625156590
- MeiHShiWPangZEGFP-EGF1 protein-conjugated PEG–PLA nanoparticles for tissue factor targeted drug deliveryBiomaterials201031215619562610.1016/j.biomaterials.2010.03.05520413154
- ChenCMeiHShiWEGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interferencePLoS One201384e6086010.1371/journal.pone.006086023593330
- EllmarkSHDustingGJFuiMNGuzzo-PernellNDrummondGRThe contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscleCardiovasc Res200565249550410.1016/j.cardiores.2004.10.02615639489
- SakataYXiangFChenZTranscription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitroArterioscler Thromb Vasc Biol200424112069207410.1161/01.ATV.0000143936.77094.a415345511
- SalcedoRPonceMLYoungHAHuman endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progressionBlood2000961344010891427
- ShiWMeiHDengJA tissue factor targeted nanomedical system for thrombi-specific drug deliveryBiomaterials201233307643765410.1016/j.biomaterials.2012.06.09422819496
- GetzGSReardonCAAnimal models of atherosclerosisArterioscler Thromb Vasc Biol20123251104111510.1161/ATVBAHA.111.23769322383700
- TaylorAShawLJFayadZTracking atherosclerosis regression: a clinical tool in preventive cardiologyAtherosclerosis2005180111010.1016/j.atherosclerosis.2004.12.02415823269
- DanhierFAnsorenaESilvaJMCocoRLe BretonAPréatVPLGA-based nanoparticles: an overview of biomedical applicationsJ Control Release2012161250552210.1016/j.jconrel.2012.01.04322353619
- VandervoortJLudwigABiocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design studyInt J Pharm20022381–2779211996812
- ZhangBWangHLiaoZEGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain gliomaBiomaterials201435134133414510.1016/j.biomaterials.2014.01.07124529623
- BreitensteinATannerFCLuscherTFTissue factor and cardiovascular disease: quo vadis?Circ J201074131219996531
- CameraMToschiVBrambillaMThe role of tissue factor in atherothrombosis and coronary artery disease: insights into platelet tissue factorSemin Thromb Hemost201541773774610.1055/s-0035-156404126408918
- LibbyPRidkerPMHanssonGKProgress and challenges in translating the biology of atherosclerosisNature2011473734731732510.1038/nature1014621593864
- ChenDXiaMHayfordCExpression of human tissue factor pathway inhibitor on vascular smooth muscle cells inhibits secretion of macrophage migration inhibitory factor and attenuates atherosclerosis in ApoE −/− miceCirculation2015131151350136010.1161/CIRCULATIONAHA.114.01342325677604
- ZhangJZuYDhanasekaraCSDetection and treatment of atherosclerosis using nanoparticlesWiley Interdiscip Rev Nanomed Nanobiotechnol201791e141210.1002/wnan.1412